SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Clinical trial NCT00096499 · COMPLETED

Trial details

NCT number: NCT00096499
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2005-04-01
Primary completion: 2007-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.